Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System

Abstract

Over the last decade knowledge of the role of astrocytes in central nervous system (CNS) neuroinflammatory diseases has changed dramatically. Rather than playing a merely passive role in response to damage it is clear that astrocytes actively maintain CNS homeostasis by influencing pH, ion and water balance, the plasticity of neurotransmitters and synapses, cerebral blood flow, and are important immune cells. During disease astrocytes become reactive and hypertrophic, a response that was long considered to be pathogenic. However, recent studies reveal that astrocytes also have a strong tissue regenerative role. Whilst most astrocyte research focuses on modulating neuronal function and synaptic transmission little is known about the cross-talk between astrocytes and oligodendrocytes, the myelinating cells of the CNS. This communication occurs via direct cell-cell contact as well as via secreted cytokines, chemokines, exosomes, and signalling molecules. Additionally, this cross-talk is important for glial development, triggering disease onset and progression, as well as stimulating regeneration and repair. Its critical role in homeostasis is most evident when this communication fails. Here, we review emerging evidence of astrocyte-oligodendrocyte communication in health and disease. Understanding the pathways involved in this cross-talk will reveal important insights into the pathogenesis and treatment of CNS diseases.

Circulating Brain Injury Exosomal Proteins following Moderate-to-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications

“…In addition, mounting evidence indicates that exosome secretion, as well as their cargoes, are linked to changes in cell phenotypes and act as local and systemic crosstalk modulators [19]. Thus, it is plausible that exosome secreted following acute TBI could function as a means to dispose and export excess of cellular material/components-products of the disease process or of disease-induced damage [20,21] that may exert long-distance pleiotropic regulatory effects (e.g., on the immune system) and also promote neuroplasticity and regeneration after injury [22].…”

The immune system on the TRAIL of Alzheimer’s disease

“…CD8+ CTLs recognize antigen presented by MHC class I on neurons to induce perforin-and/or granzyme-mediated cytolysis. In response to inflammatory events, Treg cells dampen down neuroinflammation and neurodegeneration express many complement components, including MHC class II molecules [46,47], as well as an array of cytokines and chemokines that act as chemoattractants, crucial for the recruitment of T cells into the CNS [48][49][50].…”

Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System

“…Microglia and astrocytes have a wide range of functions in the CNS, not only at baseline conditions but also in response to neuroinflammation, including providing synaptic support and maintenance, preserving metabolic homeostasis, delivering structural support, and regulating oxidative stress, phagocytosis of cellular debris and neuroinflammatory responses to intruders [306,[316][317][318][319]. As such, microglia and astrocytes support neurons and oligodendrocytes, but they also have important interactions with each other [320].…”